Eupraxia Pharmaceuticals Inc. SEC filings EPRX
Eupraxia Pharmaceuticals Inc. has 126 filings in SEC EDGAR's recent list, going back to Jul 11, 2013. Its latest annual report, Form 40-F, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 22, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 22, 2026 | Oct 22, 2026 |
| 6-K | Current report (foreign issuer) | Oct 15, 2026 | Oct 15, 2026 |
| 6-K | Current report (foreign issuer) | Oct 9, 2026 | Oct 9, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Sep 8, 2026 | Sep 8, 2026 |
| SUPPL | Filing | Sep 2, 2026 | — |
| EFFECT | Filing | Aug 24, 2026 | — |
| F-10/A | Filing | Aug 19, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 13, 2026 | Aug 13, 2026 |
| 6-K | Current report (foreign issuer) | Aug 11, 2026 | Aug 11, 2026 |
| F-X | Filing | Aug 6, 2026 | — |
| F-10 | Filing | Aug 6, 2026 | — |
| 6-K | Current report (foreign issuer) | Jul 15, 2026 | Jul 15, 2026 |
| 6-K | Current report (foreign issuer) | Jul 13, 2026 | Jul 13, 2026 |
| 6-K | Current report (foreign issuer) | Jul 7, 2026 | Jul 7, 2026 |
| 6-K | Current report (foreign issuer) | Jun 22, 2026 | Jun 19, 2026 |
| 6-K | Current report (foreign issuer) | May 29, 2026 | Jun 18, 2026 |
| 6-K | Current report (foreign issuer) | May 29, 2026 | May 28, 2026 |
| 6-K | Current report (foreign issuer) | May 28, 2026 | May 28, 2026 |
| 6-K | Current report (foreign issuer) | May 12, 2026 | May 12, 2026 |
| 6-K | Current report (foreign issuer) | May 6, 2026 | May 6, 2026 |
| 6-K | Current report (foreign issuer) | May 5, 2026 | May 5, 2026 |
| 6-K | Current report (foreign issuer) | May 1, 2026 | May 1, 2026 |
| 6-K | Current report (foreign issuer) | Apr 22, 2026 | Apr 22, 2026 |
| 6-K | Current report (foreign issuer) | Apr 21, 2026 | Apr 21, 2026 |
| 6-K | Current report (foreign issuer) | Apr 15, 2026 | Apr 14, 2026 |
| 6-K | Current report (foreign issuer) | Apr 15, 2026 | Apr 14, 2026 |
| 6-K | Current report (foreign issuer) | Mar 17, 2026 | Mar 17, 2026 |
| 40-F | Annual report (Canadian issuer) | Mar 13, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 6, 2026 | Feb 23, 2026 |
| 6-K | Current report (foreign issuer) | Feb 20, 2026 | Feb 20, 2026 |
| SUPPL | Filing | Feb 20, 2026 | — |
| 6-K | Current report (foreign issuer) | Feb 20, 2026 | Feb 19, 2026 |
| 6-K | Current report (foreign issuer) | Feb 19, 2026 | Feb 19, 2026 |
| SUPPL | Filing | Feb 18, 2026 | — |
| 6-K | Current report (foreign issuer) | Feb 18, 2026 | Feb 18, 2026 |
| S-8 | Employee stock plan registration | Feb 5, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 8, 2026 | Jan 8, 2026 |
| 6-K | Current report (foreign issuer) | Nov 13, 2025 | Nov 13, 2025 |
| 6-K | Current report (foreign issuer) | Nov 4, 2025 | Nov 4, 2025 |
| 6-K | Current report (foreign issuer) | Oct 1, 2025 | Sep 29, 2025 |
| 6-K | Current report (foreign issuer) | Sep 29, 2025 | Sep 29, 2025 |
| 6-K | Current report (foreign issuer) | Sep 24, 2025 | Sep 24, 2025 |
| SUPPL | Filing | Sep 23, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 23, 2025 | Sep 23, 2025 |
| 6-K | Current report (foreign issuer) | Sep 23, 2025 | Sep 22, 2025 |
| SUPPL | Filing | Sep 22, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 22, 2025 | Sep 22, 2025 |
| 6-K | Current report (foreign issuer) | Sep 19, 2025 | Sep 19, 2025 |
| 6-K | Current report (foreign issuer) | Sep 2, 2025 | Sep 2, 2025 |
| 6-K | Current report (foreign issuer) | Aug 13, 2025 | Aug 12, 2025 |
| 6-K | Current report (foreign issuer) | Jul 22, 2025 | Jul 22, 2025 |
| 6-K | Current report (foreign issuer) | Jul 8, 2025 | Jul 8, 2025 |
| 6-K | Current report (foreign issuer) | Jun 3, 2025 | Jun 2, 2025 |
| 6-K | Current report (foreign issuer) | Jun 2, 2025 | May 30, 2025 |
| 6-K | Current report (foreign issuer) | May 7, 2025 | May 7, 2025 |
| 6-K | Current report (foreign issuer) | May 6, 2025 | May 6, 2025 |
| 6-K | Current report (foreign issuer) | May 5, 2025 | May 5, 2025 |
| 6-K | Current report (foreign issuer) | Apr 24, 2025 | Apr 24, 2025 |
| 6-K | Current report (foreign issuer) | Mar 21, 2025 | Mar 20, 2025 |
| 40-F | Annual report (Canadian issuer) | Mar 20, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Feb 25, 2025 | Feb 25, 2025 |
| 6-K | Current report (foreign issuer) | Feb 18, 2025 | Feb 18, 2025 |
| 6-K | Current report (foreign issuer) | Nov 20, 2024 | Nov 20, 2024 |
| 6-K | Current report (foreign issuer) | Nov 14, 2024 | Nov 14, 2024 |
| 6-K | Current report (foreign issuer) | Nov 13, 2024 | Nov 13, 2024 |
| 6-K | Current report (foreign issuer) | Nov 13, 2024 | Nov 12, 2024 |
| D | Filing | Nov 8, 2024 | — |
| 6-K | Current report (foreign issuer) | Nov 7, 2024 | Nov 7, 2024 |
| 6-K | Current report (foreign issuer) | Nov 1, 2024 | Oct 31, 2024 |
| 6-K | Current report (foreign issuer) | Oct 28, 2024 | Oct 28, 2024 |
| 6-K | Current report (foreign issuer) | Oct 15, 2024 | Oct 15, 2024 |
| 6-K | Current report (foreign issuer) | Oct 10, 2024 | Oct 10, 2024 |
| 6-K | Current report (foreign issuer) | Oct 2, 2024 | Oct 2, 2024 |
| 6-K | Current report (foreign issuer) | Sep 19, 2024 | Sep 19, 2024 |
| 6-K | Current report (foreign issuer) | Sep 11, 2024 | Sep 11, 2024 |
| 6-K | Current report (foreign issuer) | Sep 4, 2024 | Sep 4, 2024 |
| 6-K | Current report (foreign issuer) | Aug 7, 2024 | Aug 7, 2024 |
| 6-K | Current report (foreign issuer) | Aug 2, 2024 | Aug 2, 2024 |
| 6-K | Current report (foreign issuer) | Jul 8, 2024 | Jul 8, 2024 |
| 6-K | Current report (foreign issuer) | Jul 3, 2024 | Jul 3, 2024 |
| 6-K | Current report (foreign issuer) | Jun 6, 2024 | Jun 6, 2024 |
| 6-K | Current report (foreign issuer) | Jun 5, 2024 | Jun 5, 2024 |
| 6-K | Current report (foreign issuer) | May 23, 2024 | May 23, 2024 |
| 6-K | Current report (foreign issuer) | May 22, 2024 | May 22, 2024 |
| 6-K | Current report (foreign issuer) | May 21, 2024 | May 21, 2024 |
| 6-K | Current report (foreign issuer) | May 15, 2024 | May 15, 2024 |
| 6-K | Current report (foreign issuer) | May 14, 2024 | May 14, 2024 |
| 6-K | Current report (foreign issuer) | May 8, 2024 | May 8, 2024 |
| 6-K | Current report (foreign issuer) | May 2, 2024 | May 2, 2024 |
| 6-K | Current report (foreign issuer) | Apr 11, 2024 | Apr 11, 2024 |
| 6-K | Current report (foreign issuer) | Apr 10, 2024 | Apr 10, 2024 |
| 6-K | Current report (foreign issuer) | Apr 8, 2024 | Apr 8, 2024 |
| 6-K | Current report (foreign issuer) | Apr 8, 2024 | Apr 8, 2024 |
| S-8 | Employee stock plan registration | Apr 5, 2024 | — |
| 6-K | Current report (foreign issuer) | Apr 5, 2024 | Apr 5, 2024 |
| CERT | Filing | Apr 4, 2024 | — |
| 6-K | Current report (foreign issuer) | Apr 3, 2024 | Apr 3, 2024 |
| 40-F | Annual report (Canadian issuer) | Apr 1, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Apr 1, 2024 | Apr 1, 2024 |
| 6-K | Current report (foreign issuer) | Mar 18, 2024 | Mar 18, 2024 |
| 6-K | Current report (foreign issuer) | Mar 15, 2024 | Mar 15, 2024 |
| 6-K | Current report (foreign issuer) | Mar 12, 2024 | Mar 12, 2024 |
| 6-K | Current report (foreign issuer) | Mar 11, 2024 | Mar 11, 2024 |
| EFFECT | Filing | Feb 7, 2024 | — |
| F-10/A | Filing | Feb 5, 2024 | — |
| 8-A12B | Filing | Jan 18, 2024 | — |
| F-X | Filing | Jan 18, 2024 | — |
| F-10 | Filing | Jan 18, 2024 | — |
| D | Filing | Aug 22, 2023 | — |
| D | Filing | Apr 18, 2016 | — |
| D | Filing | Sep 16, 2013 | — |
| D | Filing | Jul 11, 2013 | — |
| D | Filing | Jul 11, 2013 | — |
| D | Filing | Jul 11, 2013 | — |
| D | Filing | Jul 11, 2013 | — |
Showing 116 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EPRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Vancouver
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1581178
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.